mRNA capping by Venezuelan equine encephalitis virus nsP1: Functional characterization and implications for antiviral research

Journal of Virology

Volumn 89, Issue 16, 2015, Pages 8292-8303

  Li, Changqing ^a,b   Guillén, Jaime ^a,b   Rabah, Nadia ^a,b   Blanjoie, Alexandre ^c   Debart, Françoise ^c   Vasseur, Jean Jacques ^c   Canard, Bruno ^a,b   Decroly, Etienne ^a,b   Coutard, Bruno ^a,b  

^a CNRS   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5' DISPHOSPHATE RNA OLIGONUCLEOTIDE; HISTIDINE; METAL ION; MONOCLONAL ANTIBODY; NONSTRUCTURAL PROTEIN 1; NUCLEOTIDE; OLIGONUCLEOTIDE; S ADENOSYLHOMOCYSTEINE; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; CAPPED RNA; MESSENGER RNA;

ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; COVALENT BOND; DRUG RESEARCH; ENZYME ACTIVITY; ENZYME ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GUANYLYLATION; PROTEIN MODIFICATION; RNA CAPPING; SITE DIRECTED MUTAGENESIS; VENEZUELAN EQUINE ENCEPHALITIS VIRUS; VIRUS GENOME; WESTERN BLOTTING; AMINO ACID SEQUENCE; CHEMISTRY; DRUG EFFECTS; GENETICS; MOLECULAR GENETICS; SEQUENCE HOMOLOGY;

ALPHAVIRUS; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; MOLECULAR SEQUENCE DATA; RNA CAPS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84938063625     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00599-15     Document Type: Article

References (71)

1. Charrel RN, Leparc-Goffart I, Gallian P, de Lamballerie X. 2014. Globalization of Chikungunya: 10 years to invade the world. Clin Microbiol Infect 20:662-663. http://dx.doi.org/10.1111/1469-0691.12694.
2. Gould EA, Coutard B, Malet H, Morin B, Jamal S, Weaver S, Gorbalenya A, Moureau G, Baronti C, Delogu I, Forrester N, Khasnatinov M, Gritsun T, de Lamballerie X, Canard B. 2010. Understanding the alphaviruses: recent research on important emerging pathogens and progress towards their control. Antiviral Res 87:111-124. http://dx.doi.org/10.1016/j.antiviral.2009.07.007.
3. Suhrbier A, Jaffar-Bandjee MC, Gasque P. 2012. Arthritogenic alphaviruses-an overview. Nat Rev Rheumatol 8:420-429. http://dx.doi.org/10.1038/nrrheum.2012.64.
4. Adams AP, Navarro-Lopez R, Ramirez-Aguilar FJ, Lopez-Gonzalez I, Leal G, Flores-Mayorga JM, Travassos da Rosa AP, Saxton-Shaw KD, Singh AJ, Borland EM, Powers AM, Tesh RB, Weaver SC, Estrada-Franco JG. 2012. Venezuelan equine encephalitis virus activity in the Gulf Coast region of Mexico, 2003-2010. PLoS Negl Trop Dis 6:e1875. http://dx.doi.org/10.1371/journal.pntd.0001875.
5. Pisano MB, Oria G, Beskow G, Aguilar J, Konigheim B, Cacace ML, Aguirre L, Stein M, Contigiani MS. 2013. Venezuelan equine encephalitis viruses (VEEV) in Argentina: serological evidence of human infection. PLoS Negl Trop Dis 7:e2551. http://dx.doi.org/10.1371/journal.pntd.0002551.
6. Rivas F, Diaz LA, Cardenas VM, Daza E, Bruzon L, Alcala A, De la Hoz O, Caceres FM, Aristizabal G, Martinez JW, Revelo D, De la Hoz F, Boshell J, Camacho T, Calderon L, Olano VA, Villarreal LI, Roselli D, Alvarez G, Ludwig G, Tsai T. 1997. Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J Infect Dis 175:828-832. http://dx.doi.org/10.1086/513978.
7. Weaver SC, Salas R, Rico-Hesse R, Ludwig GV, Oberste MS, Boshell J, Tesh RB. 1996. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Lancet 348:436-440.
8. Aguilar PV, Estrada-Franco JG, Navarro-Lopez R, Ferro C, Haddow AD, Weaver SC. 2011. Endemic Venezuelan equine encephalitis in the Americas: hidden under the dengue umbrella. Future Virol 6:721-740. http://dx.doi.org/10.2217/fvl.11.50.
9. Johnson KM, Martin DH. 1974. Venezuelan equine encephalitis. Adv Vet Sci Comp Med 18:79-116.
10. León CA. 1975. Sequelae of Venezuelan equine encephalitis in humans: a four year follow-up. Int J Epidemiol 4:131-140. http://dx.doi.org/10.1093/ije/4.2.131.
11. Taylor KG, Paessler S. 2013. Pathogenesis of Venezuelan equine encephalitis. Vet Microbiol 167:145-150. http://dx.doi.org/10.1016/j.vetmic.2013.07.012.
12. Chung D, Schroeder CE, Sotsky J, Yao T, Roy S, Smith RA, Tower NA, Noah JW, McKellip S, Sosa M, Rasmussen L, White EL, Aube J, Golden JE. 2013. ML336: development of quinazolinone-based inhibitors against Venezuelan equine encephalitis virus (VEEV). Probe reports from the NIH Molecular Libraries Program. National Center for Biotechnology Information, Bethesda, MD. http://www.ncbi.nlm.nih.gov/books/NBK179829/?report=reader#!po=1.85185.
13. Chung DH, Jonsson CB, Tower NA, Chu YK, Sahin E, Golden JE, Noah JW, Schroeder CE, Sotsky JB, Sosa MI, Cramer DE, McKellip SN, Rasmussen L, White EL, Schmaljohn CS, Julander JG, Smith JM, Filone CM, Connor JH, Sakurai Y, Davey RA. 2014. Discovery of a novel compound with anti-Venezuelan equine encephalitis virus activity that targets the nonstructural protein 2. PLoS Pathog 10:e1004213. http://dx.doi.org/10.1371/journal.ppat.1004213.
14. Julander JG, Bowen RA, Rao JR, Day C, Shafer K, Smee DF, Morrey JD, Chu CK. 2008. Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine. Antiviral Res 80:309-315. http://dx.doi.org/10.1016/j.antiviral.2008.07.002.
15. Hyde JL, Gardner CL, Kimura T, White JP, Liu G, Trobaugh DW, Huang C, Tonelli M, Paessler S, Takeda K, Klimstra WB, Amarasinghe GK, Diamond MS. 2014. A viral RNA structural element alters host recognition of nonself RNA. Science 343:783-787. http://dx.doi.org/10.1126/science.1248465.
16. Decroly E, Ferron F, Lescar J, Canard B. 2012. Conventional and unconventional mechanisms for capping viral mRNA. Nat Rev Microbiol 10:51-65.
17. Mi S, Durbin R, Huang HV, Rice CM, Stollar V. 1989. Association of the Sindbis virus RNA methyltransferase activity with the nonstructural proteinnsP1. Virology170:385-391.http://dx.doi.org/10.1016/0042-6822(89)90429-7.
18. Laakkonen P, Hyvonen M, Peranen J, Kaariainen L. 1994. Expression of Semliki Forest virus nsP1-specific methyltransferase in insect cells and in Escherichia coli. J Virol 68:7418-7425.
19. Mi S, Stollar V. 1991. Expression of Sindbis virus nsP1 and methyltransferase activity in Escherichia coli. Virology 184:423-427. http://dx.doi.org/10.1016/0042-6822(91)90862-6.
20. Rozanov MN, Koonin EV, Gorbalenya AE. 1992. Conservation of the putative methyltransferase domain: a hallmark of the 'Sindbis-like' supergroup of positive-strand RNA viruses. J Gen Virol 73(Part 8):2129-2134.
21. Ahola T, Kaariainen L. 1995. Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP. Proc Natl Acad Sci U S A 92:507-511. http://dx.doi.org/10.1073/pnas.92.2.507.
22. Ahola T, Laakkonen P, Vihinen H, Kaariainen L. 1997. Critical residues of Semliki Forest virus RNA capping enzyme involved in methyltransferase and guanylyltransferase-like activities. J Virol 71:392-397.
23. Lin HY, Yu CY, Hsu YH, Meng M. 2012. Functional analysis of the conserved histidine residue of Bamboo mosaic virus capping enzyme in the activity for the formation of the covalent enzyme-m7GMP intermediate. FEBS Lett 586:2326-2331. http://dx.doi.org/10.1016/j.febslet.2012.05.024.
24. Ahola T, Lampio A, Auvinen P, Kaariainen L. 1999. Semliki Forest virus mRNA capping enzyme requires association with anionic membrane phospholipids for activity. EMBO J 18:3164-3172. http://dx.doi.org/10.1093/emboj/18.11.3164.
25. Spuul P, Salonen A, Merits A, Jokitalo E, Kaariainen L, Ahola T. 2007. Role of the amphipathic peptide of Semliki Forest virus replicase protein nsP1 in membrane association and virus replication. J Virol 81:872-883. http://dx.doi.org/10.1128/JVI.01785-06.
26. Lampio A, Kilpelainen I, Pesonen S, Karhi K, Auvinen P, Somerharju P, Kaariainen L. 2000. Membrane binding mechanism of an RNA viruscapping enzyme. J Biol Chem 275:37853-37859. http://dx.doi.org/10.1074/jbc.M004865200.
27. Ahola T, Kujala P, Tuittila M, Blom T, Laakkonen P, Hinkkanen A, Auvinen P. 2000. Effects of palmitoylation of replicase protein nsP1 on alphavirus infection. J Virol 74:6725-6733. http://dx.doi.org/10.1128/JVI.74.15.6725-6733.2000.
28. Laakkonen P, Ahola T, Kaariainen L. 1996. The effects of palmitoylation on membrane association of Semliki Forest virus RNA capping enzyme. J Biol Chem 271:28567-28571. http://dx.doi.org/10.1074/jbc.271.45.28567.
29. Tomar S, Narwal M, Harms E, Smith JL, Kuhn RJ. 2011. Heterologous production, purification and characterization of enzymatically active Sindbis virus nonstructural protein nsP1. Protein Expr Purif 79:277-284. http://dx.doi.org/10.1016/j.pep.2011.05.022.
30. Gorbalenya AE, Koonin EV, Donchenko AP, Blinov VM. 1988. A novel superfamily of nucleoside triphosphate-binding motif containing proteins which are probably involved in duplex unwinding in DNA and RNA replication and recombination. FEBS Lett 235:16-24. http://dx.doi.org/10.1016/0014-5793(88)81226-2.
31. Hodgman TC. 1988. A new superfamily of replicative proteins. Nature 333:22-23.
32. Karpe YA, Aher PP, Lole KS. 2011. NTPase and 5'-RNA triphosphatase activities of Chikungunya virus nsP2 protein. PLoS One 6:e22336.
33. Vasiljeva L, Merits A, Auvinen P, Kaariainen L. 2000. Identification of a novel function of the alphavirus capping apparatus. RNA 5'-triphosphatase activity of Nsp2. J Biol Chem 275:17281-17287.
34. Huang YL, Hsu YH, Han YT, Meng M. 2005. mRNA guanylation catalyzed by the S-adenosylmethionine-dependent guanylyltransferase of bamboo mosaic virus. J Biol Chem 280:13153-13162. http://dx.doi.org/10.1074/jbc.M412619200.
35. Lantez V, Dalle K, Charrel R, Baronti C, Canard B, Coutard B. 2011. Comparative production analysis of three phlebovirus nucleoproteins under denaturing or non-denaturing conditions for crystallographic studies. PLoS Negl Trop Dis 5:e936. http://dx.doi.org/10.1371/journal.pntd.0000936.
36. Lavergne T, Bertrand JR, Vasseur JJ, Debart F. 2008. A base-labile group for 2'-OH protection of ribonucleosides: a major challenge for RNA synthesis. Chemistry 14:9135-9138. http://dx.doi.org/10.1002/chem.200801392.
37. Lavergne T, Janin M, Dupouy C, Vasseur JJ, Debart F. 2010. Chemical synthesis of RNA with base-labile 2'-O-(pivaloyloxymethyl)-protected ribonucleoside phosphoramidites. Curr Protoc Nucleic Acid Chem Chapter 3:Unit 3.19. http://dx.doi.org/10.1002/0471142700.nc0319s43.
38. Zlatev I, Lavergne T, Debart F, Vasseur JJ, Manoharan M, Morvan F. 2010. Efficient solid-phase chemical synthesis of 5'-triphosphates of DNA, RNA, and their analogues. Org Lett 12:2190-2193. http://dx.doi.org/10.1021/ol1004214.
39. Fata CL, Sawicki SG, Sawicki DL. 2002. Modification of Asn374 of nsP1 suppresses a Sindbis virus nsP4 minus-strand polymerase mutant. J Virol 76:8641-8649. http://dx.doi.org/10.1128/JVI.76.17.8641-8649.2002.
40. Lulla V, Sawicki DL, Sawicki SG, Lulla A, Merits A, Ahola T. 2008. Molecular defects caused by temperature-sensitive mutations in Semliki Forest virus nsP1. J Virol 82:9236-9244. http://dx.doi.org/10.1128/JVI.00711-08.
41. Rupp JC, Jundt N, Hardy RW. 2011. Requirement for the aminoterminal domain of Sindbis virus nsP4 during virus infection. J Virol 85: 3449-3460. http://dx.doi.org/10.1128/JVI.02058-10.
42. Bochnig P, Reuter R, Bringmann P, Luhrmann R. 1987. A monoclonal antibody against 2,2,7-trimethylguanosine that reacts with intact, class U, small nuclear ribonucleoproteins as well as with 7-methylguanosinecapped RNAs. Eur J Biochem 168:461-467. http://dx.doi.org/10.1111/j.1432-1033.1987.tb13439.x.
43. Shuman S, Hurwitz J. 1981. Mechanism of mRNA capping by vaccinia virus guanylyltransferase: characterization of an enzyme-guanylate intermediate. Proc Natl Acad Sci U S A 78:187-191. http://dx.doi.org/10.1073/pnas.78.1.187.
44. Duclos B, Marcandier S, Cozzone AJ. 1991. Chemical properties and separation of phosphoamino acids by thin-layer chromatography and/or electrophoresis. Methods Enzymol 201:10-21.
45. Gottlin EB, Rudolph AE, Zhao Y, Matthews HR, Dixon JE. 1998. Catalytic mechanism of the phospholipase D superfamily proceeds via a covalent phosphohistidine intermediate. Proc Natl Acad Sci U S A 95: 9202-9207. http://dx.doi.org/10.1073/pnas.95.16.9202.
46. Ogino T, Banerjee AK. 2007. Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus. Mol Cell 25:85-97. http://dx.doi.org/10.1016/j.molcel.2006.11.013.
47. Toyama R, Mizumoto K, Nakahara Y, Tatsuno T, Kaziro Y. 1983. Mechanism of the mRNA guanylyltransferase reaction: isolation of N epsilon-phospholysine and GMP (5' leads to N epsilon) lysine from the guanylyl-enzyme intermediate. EMBO J 2:2195-2201.
48. Venkatesan S, Moss B. 1982. Eukaryotic mRNA capping enzymeguanylate covalent intermediate. Proc Natl Acad Sci U S A 79:340-344. http://dx.doi.org/10.1073/pnas.79.2.340.
49. Raae AJ, Kleppe K. 1978. Effect of ATP analogues on T4 polynucleotide ligase. Biochem Biophys Res Commun 81:24-27. http://dx.doi.org/10.1016/0006-291X(78)91625-X.
50. Barral K, Sallamand C, Petzold C, Coutard B, Collet A, Thillier Y, Zimmermann J, Vasseur JJ, Canard B, Rohayem J, Debart F, Decroly E. 2013. Development of specific dengue virus 2'-O-and N7-methyltransferase assays for antiviral drug screening. Antiviral Res 99: 292-300. http://dx.doi.org/10.1016/j.antiviral.2013.06.001.
51. Decroly E, Debarnot C, Ferron F, Bouvet M, Coutard B, Imbert I, Gluais L, Papageorgiou N, Sharff A, Bricogne G, Ortiz-Lombardia M, Lescar J, Canard B. 2011. Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/ nsp16 complex. PLoS Pathog 7:e1002059. http://dx.doi.org/10.1371/journal.ppat.1002059.
52. Pugh CS, Borchardt RT, Stone HO. 1977. Inhibition of Newcastle disease virion messenger RNA (guanine-7-)-methyltransferase by analogues of S-adenosylhomocysteine. Biochemistry 16:3928-3932. http://dx.doi.org/10.1021/bi00636a032.
53. Milani M, Mastrangelo E, Bollati M, Selisko B, Decroly E, Bouvet M, Canard B, Bolognesi M. 2009. Flaviviral methyltransferase/RNA interaction: structural basis for enzyme inhibition. Antiviral Res 83:28-34. http://dx.doi.org/10.1016/j.antiviral.2009.03.001.
54. Scheidel LM, Stollar V. 1991. Mutations that confer resistance to mycophenolic acid and ribavirin on Sindbis virus map to the nonstructural protein nsP1. Virology 181:490-499. http://dx.doi.org/10.1016/0042-6822(91)90881-B.
55. Decroly E, Imbert I, Coutard B, Bouvet M, Selisko B, Alvarez K, Gorbalenya AE, Snijder EJ, Canard B. 2008. Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity. J Virol 82:8071-8084. http://dx.doi.org/10.1128/JVI.00407-08.
56. Pugh CS, Borchardt RT, Stone HO. 1978. Sinefungin, a potent inhibitor of virion mRNA(guanine-7-)-methyltransferase, mRNA(nucleoside-2'-)-methyltransferase, and viral multiplication. J Biol Chem 253:4075-4077.
57. Huang YL, Han YT, Chang YT, Hsu YH, Meng M. 2004. Critical residues for GTP methylation and formation of the covalent m7GMPenzyme intermediate in the capping enzyme domain of bamboo mosaic virus. J Virol 78:1271-1280. http://dx.doi.org/10.1128/JVI.78.3.1271-1280.2004.
58. Gullberg RC, Jordan Steel J, Moon SL, Soltani E, Geiss BJ. 2015. Oxidative stress influences positive strand RNA virus genome synthesis and capping. Virology 475:219-229. http://dx.doi.org/10.1016/j.virol.2014.10.037.
59. Lampio A, Ahola T, Darzynkiewicz E, Stepinski J, Jankowska-Anyszka M, Kaariainen L. 1999. Guanosine nucleotide analogs as inhibitors of alphavirus mRNA capping enzyme. Antiviral Res 42:35-46. http://dx.doi.org/10.1016/S0166-3542(99)00011-X.
60. Ogino T, Banerjee AK. 2008. Formation of guanosine(5')tetraphospho(5') adenosine cap structure by an unconventional mRNA capping enzyme of vesicular stomatitis virus. J Virol 82:7729-7734. http://dx.doi.org/10.1128/JVI.00326-08.
61. Ingrosso D, Fowler AV, Bleibaum J, Clarke S. 1989. Sequence of the D-aspartyl/L-isoaspartyl protein methyltransferase from human erythrocytes. Common sequence motifs for protein, DNA, RNA, and small molecule S-adenosylmethionine-dependent methyltransferases. J Biol Chem 264:20131-20139.
62. Rutherford K, Daggett V. 2009. A hotspot of inactivation: the A22S and V108M polymorphisms individually destabilize the active site structure of catechol O-methyltransferase. Biochemistry 48:6450-6460. http://dx.doi.org/10.1021/bi900174v.
63. Wang YF, Sawicki SG, Sawicki DL. 1991. Sindbis virus nsP1 functions in negative-strand RNA synthesis. J Virol 65:985-988.
64. Shirako Y, Strauss EG, Strauss JH. 2000. Suppressor mutations that allow Sindbis virus RNA polymerase to function with nonaromatic amino acids at the N-terminus: evidence for interaction between nsP1 and nsP4 in minus-strand RNA synthesis. Virology 276:148-160. http://dx.doi.org/10.1006/viro.2000.0544.
65. Hashem AM, Flaman AS, Farnsworth A, Brown EG, Van Domselaar G, He R, Li X. 2009. Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases. PLoS One 4:e8350. http://dx.doi.org/10.1371/journal.pone.0008350.
66. Shadrick WR, Mukherjee S, Hanson AM, Sweeney NL, Frick DN. 2013. Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP. Biochemistry 52:6151-6159. http://dx.doi.org/10.1021/bi4006495.
67. Ölschläger S, Neyts J, Günther S. 2011. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus. Antiviral Res 91:89-93.
68. Liao HJ, Stollar V. 1993. Reversal of the antiviral activity of ribavirin against Sindbis virus in Ae. albopictus mosquito cells. Antiviral Res 22: 285-294. http://dx.doi.org/10.1016/0166-3542(93)90038-K.
69. Hyde JL, Chen R, Trobaugh DW, Diamond MS, Weaver SC, Klimstra WB, Wilusz J. 25 January 2015. The 5' and 3' ends of alphavirus RNAs-non-coding is not non-functional. Virus Res http://dx.doi.org/10.1016/j.virusres.2015.01.016.
70. Notredame C, Higgins DG, Heringa J. 2000. T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 302:205-217. http://dx.doi.org/10.1006/jmbi.2000.4042.
71. McGuffin LJ, Bryson K, Jones DT. 2000. The PSIPRED protein structure prediction server. Bioinformatics 16:404-405. http://dx.doi.org/10.1093/bioinformatics/16.4.404.